LEADING LVAD COMPANY IN THE STATE OF TEXAS
Evaheart, Inc. ("EVI") is a medical device company based in the Texas Medical Center of Houston. EVI was established to gain regulatory approval and commercialize the EVAHEART®2 Left Ventricular Assist System in the North American market and start distribution in Europe. Under an FDA-approved IDE, a Multi-Center Prospective Randomized Clinical Trial (COMPETENCE TRIAL) of the EVAHEART®2 LVAS is currently ongoing in US.
OUR MISSION
To return severe heart failure patients to their home with high quality of life.
WHAT WE'VE ACHIEVED
- Over 9-year durability testing with no mechanical failure.
- Regulatory clearance granted (by PMDA) and now clinically used in Japan
- Total 183 EVAHEART® LVAS have been implanted to-date (July-2018).
- IDE (Investigational Device Exemption) approved by the FDA.
- IDE clinical trial (BTT trial) in North America is underway.
- New miniaturized pump and inflow cannula are implemented.
"RESPECT PULSATILITY"
Company Details
- Employees
- 14
- Founded
- 2014
- Address
- 4900 Fournace Pl,
- Phone
- 1 (713) 520-7979
- in****@****usa.com
- Industry
- Biotechnology
- Website
- evaheart-usa.com
- HQ
- Bellaire, Texas
Evaheart, Inc. Questions
Evaheart, Inc.'s helpline number is 1 (713) 520-7979
Evaheart, Inc.'s website is evaheart-usa.com
Evaheart, Inc.'s LinkedIn profile is https://www.linkedin.com/company/evaheart-inc
Evaheart, Inc. has
14 employees.
View email and phone details for 14
employees at Evaheart, Inc..
Evaheart, Inc.'s industry is
Biotechnology
Evaheart, Inc.'s top competitors are
Bivacor,
Velentium Medical,
Biotex Inc,
Spark Biomedical Inc,
Prana Surgical,
Alleviant Medical,
Procyrion, Inc.,
Millar,
Saranas,
Nyra Medical.
Evaheart, Inc.'s support email address is info@evaheart-usa.com
Evaheart, Inc.'s categories are Biotechnology
Evaheart, Inc.'s founding year is 2014
